Recommended Pages at businessweek.com

Google's Brin Makes Strides on Parkinson's Cure - Businessweek

businessweek.com — “Sergey Brin, the 38-year-old co- founder of Google Inc. (GOOG), is making strides in his quest to find a cure for Parkinson’s, a progressive disease his DNA and family history suggest may afflict him as early as 10 years from now.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on May 11, 2012 at 1:23 pm By:

matthewherper Matthew Herper

Trying again: @RobertLangreth profiles Sergey Brin and his work on Parkinson's. http://t.co/EuOQjp5N

2 weeks ago...

Girish Navani: Examining a City's Health - Businessweek

businessweek.com — “Understanding the health of a community is difficult. Surveys cost millions of dollars and take months to figure out how diseases such as obesity or diabetes affect a population. They’re too slow to spot fast-moving illnesses like the flu.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on May 7, 2012 at 10:40 am By:

ecamhi Eli Camhi Health IT and Social Worker

Girish Navani: Examining a City's Health http://t.co/iBKMnLB0 via @BW

3 weeks ago...

CareFusion 3Q profit falls on sale of Nicolet unit - BusinessWeek

businessweek.com — “Medical device maker CareFusion Corp. said Thursday that its profit fell 31 percent in the fiscal third quarter as it took a loss on its neurodiagnostic business, which it has agreed to sell.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 6:22 am By:

Drugs_Devices Drugs and Devices OW OW Health

CareFusion 3Q profit falls on sale of Nicolet unit - BusinessWeek: CareFusion 3Q profit falls on sale... http://t.co/jD0nYCqw #MedDevice

3 weeks ago...

Aveo takes 1Q loss as drug development continues - BusinessWeek

businessweek.com — “Aveo Pharmaceuticals Inc. said Thursday it took a loss in the first quarter as it continued development of two experimental cancer drugs.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on May 4, 2012 at 5:45 am By:

Drugs_Devices Drugs and Devices OW OW Health

Aveo takes 1Q loss as drug development continues - BusinessWeek: Updated NewsAveo takes 1Q loss as drug de... http://t.co/NyPVouhZ #drug

3 weeks ago...

Regulators Eye a Maneuver Meant to Cut Health-Care Costs - Businessweek

businessweek.com — “Insurance markets can be unraveled by adverse selection: If people who need insurance less don’t pay into the risk pool, that raises the costs for everyone left. That’s why the health-reform law has mandates for both individuals and employers with 50 or more employees: Everybody pays in to makeView full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on May 1, 2012 at 8:17 pm By:

healthcarewire Healthcare Wire Health News

Regulators Eye a Maneuver Meant to Cut Health-Care Costs: Federal regulators are now scrutinizing whether small ... http://t.co/wmuv7uhR

4 weeks ago...

Cancer survivors urged to eat better, exercise - BusinessWeek

businessweek.com — “A cancer diagnosis often inspires people to exercise and eat healthier. Now the experts say there's strong evidence that both habits may help prevent the disease from coming back.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 27, 2012 at 1:03 pm By:

Rndubois Raymond DuBois Physician, Doctor, Internist, Gastroenterologist, and Health Executive

Group Urges Physicians To Talk To Cancer Survivors About Exercise, Healthy Diet.: http://t.co/4iUgJ8ZB

1 month ago...

CDC: 2011 was worst measles year in US in 15 years - BusinessWeek

businessweek.com — “Last year was the worst year for measles in the U.S. in 15 years, health officials said Thursday.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 20, 2012 at 12:05 pm By:

Public Citizen wants withdrawal of diabetes drug - BusinessWeek

businessweek.com — “A consumer advocacy group is calling on government regulators to withdraw a diabetes drug from Novo Nordisk, saying the injectable medication raises the risk of thyroid cancer, pancreatitis and kidney failure.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 20, 2012 at 5:23 am By:

Drugs_Devices Drugs and Devices OW OW Health

Public Citizen wants withdrawal of diabetes drug - BusinessWeek: Updated NewsPublic Citizen wants withdraw... http://t.co/5BLL6LQw #drug

1 month ago...

Dow, Monsanto Herbicide-Tolerant Crops Need U.S. Study - Businessweek

businessweek.com — “A coalition of vegetable growers wants U.S. regulators to study the potential damage facing their fields from a new generation of herbicide-tolerant crops developed by Dow Chemical Co. (DOW) and Monsanto Co. (MON)View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 18, 2012 at 8:43 pm By:

NaomiStarkman Naomi Starkman

Dow, Monsanto Herbicide-Tolerant Crops Need U.S. Study http://t.co/SEm7xDLH #pesticide #foodsafety

1 month ago...

Endocyte could get $1B from Merck development deal - BusinessWeek

businessweek.com — “Endocyte Inc. said Monday that Merck & Co. will help develop and market its experimental cancer drug vintafolide, and Endocyte could get more than $1 billion if the drug is successfully developed as a treatment for multiple types of cancer.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 16, 2012 at 8:46 pm By:

drpdtapp Dr. P. D Tapp Doctor, Health Executive, and PhD

Merck to buy Endocyte cancer therapy for as much as $1B if tests are successful. http://t.co/cG7H3qTw

1 month ago...

Jury rules against J&J subsidiary in Arkansas - BusinessWeek

businessweek.com — “A Johnson & Johnson subsidiary downplayed and hid risks associated with the antipsychotic drug Risperdal, a jury determined Tuesday in Arkansas' billion-dollar lawsuit against Janssen Pharmaceuticals Inc.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 11, 2012 at 5:11 am By:

Drugs_Devices Drugs and Devices OW OW Health

Jury rules against J&J subsidiary in Arkansas - BusinessWeek: ABC6OnYourSide.comJury rules against J&J sub... http://t.co/i0gN6svd #drug

2 months ago...

Diamond Naturals dog food variety recalled - BusinessWeek

businessweek.com — “Diamond Pet Foods says it is voluntarily recalling its Diamond Naturals Lamb Meal & Rice dry dog food because the product may be contaminated with salmonella.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 9, 2012 at 7:05 pm By:

KingmanPetDoc SH Animal Hospital Veterinarian

*Diamond Pet Food Recall*- Diamond Naturals Lamb Meal & Rice dry dog food is being recalled because the product... http://t.co/AwLqUGYc

2 months ago...

Kidney Failure Devices to Receive Fast-Track FDA Reviews - Businessweek

businessweek.com — “A wearable artificial kidney and two other devices to treat renal failure will get fast-track reviews under a program U.S. regulators say can cut the time it takes to get “breakthrough” medical technology to market.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 9, 2012 at 6:01 pm By:

BAAKP Bay Area Kidney Support

Kidney Disease Devices Get Fast-Track Reviews http://t.co/XeWHNnIP

2 months ago...

Bayer Loses Bid to Bar Class Action in Sex-Bias Lawsuit - Businessweek

businessweek.com — “U.S. units of German drugmaker Bayer AG (BAYN) failed to prevent eight women from pursuing a group lawsuit claiming the company discriminated in pay and promotions, and showed bias based on pregnancy and family responsibilities.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on April 3, 2012 at 1:30 pm By:

FiercePharma FiercePharma Health Site

Bayer fails to block class-action status for 8 women's sex-discrimination claims—Bloomberg http://t.co/GhEKQFof $BAY #pharma

2 months ago...

FDA rejects call to ban BPA from food packaging - BusinessWeek

businessweek.com — “The Food and Drug Administration has rejected a petition from environmentalists that would have banned the plastic-hardening chemical bisphenol-A from all food and drink packaging, including plastic bottles and canned food.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on March 30, 2012 at 9:59 pm By:

expecting411 Ari Brown Doctor, Pediatrician, and Physician

FDA says they won't ban BPA from food packaging. There is not enough evidence of adverse health effects. Research... http://t.co/t4sYJ8La

2 months ago...

 1 2 3 4 Next ›  Last »